Literature DB >> 6487754

Comparison of the erythrocyte partitioning method with two classical methods for estimating free drug fraction in plasma.

A H Trung, G Sirois, L M Dubé, I J McGilveray.   

Abstract

A modification of the erythrocyte partitioning method for the rapid estimation of plasma-free drug fractions (fu) is described and applied to five basic drugs. In the procedure, which uses readily available clinical laboratory equipment, fu is calculated from measurements of drug partitioning between plasma and erythrocytes, and between buffer and erythrocytes. Results obtained are compared with those from equilibrium dialysis or ultrafiltration techniques for amitriptyline, imipramine, quinidine, lidocaine, and propranolol. For each drug, the mean value of fu obtained with the erythrocyte partitioning procedure was not found to be significantly different from that determined by one of the two other classical techniques. The erythrocyte partitioning method lead to reproducible (mean C.V. = 6.25) and precise values of fu when compared to the other methods; its clinical application to lidocaine gave results which agreed with those obtained by equilibrium dialysis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6487754     DOI: 10.1002/bdd.2510050310

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  3 in total

1.  Pharmacokinetics of the cyclosporine-ketoconazole interaction in dogs.

Authors:  A D'mello; R Venkataramanan; M Satake; S Todo; S Takaya; R J Ptachcinski; G J Burckart; T E Starzl
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1989-06

2.  Blood protein binding of cyclosporine in transplant patients.

Authors:  I Zaghloul; R J Ptachcinski; G J Burckart; D Van Thiel; T E Starzel; R Venkataramanan
Journal:  J Clin Pharmacol       Date:  1987-03       Impact factor: 3.126

3.  Plasma protein binding of amiodarone in a patient population: measurement by erythrocyte partitioning and a novel glass-binding method.

Authors:  M E Veronese; S McLean; R Hendriks
Journal:  Br J Clin Pharmacol       Date:  1988-12       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.